January 23, 2024
DOI : 10.56831/PSMPH-04-117
The most prevalent modifiable cause of atherosclerotic cardiovascular disease is hyperlipidemia. The notion of the inverse link between the onset of a major adverse cardiovascular event and non- high-density lipoprotein (non-HDL) and low-density lipoprotein (LDL-C) cholesterol has emerged from our understanding of controlling hyperlipidemia. An overview of lipids and their metabolism will be given in this review. It will also address hyperlipidemia and therapeutic strategies for it.
Keywords: low density lipoprotein-cholesterol; statin-induced myopathy; lipid metabolism